Rossicaside B is primarily studied for its potential neuroprotective properties. It has shown activity in supporting neuronal cell survival under stress conditions, making it a compound of interest in research related to neurodegenerative disorders such as Alzheimer's and Parkinson's diseases. It may modulate signaling pathways involved in oxidative stress and inflammation in brain tissue. Due to its natural origin and structural profile, it is also explored for use in developing cognitive-enhancing agents and therapies aimed at improving brain resilience. Current applications remain in the preclinical research stage, focusing on mechanism studies and efficacy in cellular and animal models.